Skip to main content
NCD 20.14 · version 1

NCD 20.14: Plethysmography

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database NCDs: API snapshot September 27, 2026 (effective September 20, 2026). Next CMS release: weekly, every Thursday.

Medicare Coverage Database NCDs: the loaded version is API snapshot September 27, 2026, and the CMS schedule called for a newer one from October 1, 2026. Verify figures against the current CMS publication until this reference is rebuilt; pages built on it are withdrawn from search indexing until then.

Key facts for NCD 20.14

Benefit category
Diagnostic Tests (other)
Effective date
11/15/1980
Transmittal
n/a
Versions published
1
Manual section
20
Cardiovascular System, NCD Manual (Pub. 100-03) chapter 1 part 1

TL;DR

NCD 20.14 sets Medicare's national policy for plethysmography under the benefit category "Diagnostic Tests (other)", effective 11/15/1980. Medicare coverage is extended to those procedures listed in Category I below when used for the accepted medical indications mentioned above. The procedures in Category II are still considered experimental and are not covered at this time. Denial of claims… It has been revised once since publication and binds every Medicare Administrative Contractor nationally.

Item or service described

Plethysmography involves the measurement and recording (by one of several methods) of changes in the size of a body part as modified by the circulation of blood in that part.

Plethysmography is of value as a noninvasive technique for diagnostic, preoperative and postoperative evaluation of peripheral artery disease in the internal medicine or vascular surgery practice. It is also a useful tool for the preoperative podiatric evaluation of the diabetic patient or one who has intermittent claudication or other signs or symptoms indicative of peripheral vascular disease which have a bearing on the patient's candidacy for foot surgery.

The oldest form of plethysmography is the venous occlusive pneumoplethysmography. This method is cumbersome, time consuming, and requires considerable training to give useful, reproducible results. Nonetheless, in the setting of the hospital vascular laboratory, this technique is considered a reasonable and necessary procedure for the diagnostic evaluation of suspected peripheral arterial disease. It is unsuitable for routine use in the physician's office.

Recently, however, a number of other plethysmographic methods have been developed which make use of phenomena such as changes in electric impedance or changes in segmental blood pressure at constant volume to assess regional perfusion. Several of these methods have reached a level of development which makes them clinically valuable.

Indications and limitations of coverage

Medicare coverage is extended to those procedures listed in Category I below when used for the accepted medical indications mentioned above. The procedures in Category II are still considered experimental and are not covered at this time. Denial of claims because a noncovered procedure was used or because there was no medical indication for plethysmographic evaluation of any type should be based on §1862(a)(1) of the Act.

Category I - Covered

Segmental Plethysmography - Included under this procedure are services performed with a regional plethysmograph, differential plethysmograph, recording oscillometer, and a pulse volume recorder.

Electrical Impedance Plethysmography

Ultrasonic Measurement of Blood Flow (Doppler) - While not strictly a plethysmographic method, this is also a useful tool in the evaluation of suspected peripheral vascular disease or preoperative screening of podiatric patients with suspected peripheral vascular compromise. (See §50-7 for the applicable coverage policy on this procedure.)

Oculoplethysmography - See NCD on Noninvasive Tests of Carotid Function, § 20.17 .

Strain Gauge Plethysmography - This test is based on recording the non-pulsatile aspects of inflowing blood at various points on an extremity by a mercury-in-silastic strain gauge sensor. The instrument consists of a chart recorder, an automatic cuff inflation and deflation system, and a recording manometer.

Category II - Experimental

The following methods have not yet reached a level of development such as to allow their routine use in the evaluation of suspected peripheral vascular disease.

Inductance Plethysmography - This method is considered experimental and does not provide reproducible results.

Capacitance Plethysmography - This method is considered experimental and does not provide reproducible results.

Mechanical Oscillometry - This is a non-standardized method which offers poor sensitivity and is not considered superior to the simple measurement of peripheral blood pressure.

Photoelectric Plethysmography - This method is considered useful only in determining whether or not a pulse is present and does not provide reproducible measurements of blood flow.

Differential plethysmography, on the other hand, is a system which uses an impedance technique to compare pulse pressures at various points along a limb, with a reference pressure at the mid-brachial or wrist level. It is not clear whether this technique, as usually performed in the physician's office, meets the definition of plethysmography because quantitative measurements of blood flow are usually not made. It has been concluded, in any event, that the differential plethysmography system is a blood pulse recorder of undetermined value, which has the potential for significant overutilization. Therefore, reimbursement for studies done by techniques other than venous occlusive pneumoplethysmography should be denied, at least until additional data on these devices, including controlled clinical studies, become available.

Text reproduced from the CMS Medicare Coverage Database record for NCD 20.14 version 1. View the original on cms.gov.

Local policies that build on this NCD

10 active Local Coverage Determinations cite NCD 20.14 among their related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.

How MACs bill NCD 20.14

A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 5 current articles in the Medicare Coverage Database name NCD 20.14, 5 of them with a covered ICD-10-CM list, from 4 contractors. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.

A56697: Billing and Coding: Non-Invasive Vascular Studies

Billing and Coding, effective 2026-11-05 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record

1,440 covered ICD-10-CM codes in 8 groups; 22 procedure codes: 93880, 93882, 93886, 93888, 93892, 93893, 93922, 93923, 93924, 93925, 93926, 93930 and 10 more. Local policy: L34045 Non-Invasive Vascular Studies. Check a diagnosis for 93880.

First covered codes: G04.1 Tropical spastic paraplegia; G45.0 Vertebro-basilar artery syndrome; G45.1 Carotid artery syndrome (hemispheric); G45.2 Multiple and bilateral precerebral artery syndromes; G45.3 Amaurosis fugax; G45.4 Transient global amnesia; …

A57593: Billing and Coding: Non-Invasive Peripheral Arterial Vascular Studies

Billing and Coding, effective 2025-10-01 · Wisconsin Physicians Service Insurance Corporation (05101, 05102, 05201, 05202, 05301, 05302, 05401, 05402, 05901, 08101, 08102, 08201, 08202) · CMS record

593 covered ICD-10-CM codes; 7 procedure codes: 93922, 93923, 93924, 93925, 93926, 93930, 93931. Local policy: L35761 Non-Invasive Peripheral Arterial Vascular Studies. Check a diagnosis for 93922.

First covered codes: A48.0 Gas gangrene; E08.51 Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy without gangrene; E08.52 Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene; E08.59 Diabetes mellitus due to underlying condition with other circulatory complications; E09.51 Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy without gangrene; E09.52 Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene; …

A57594: Billing and Coding: Non-Invasive Peripheral Venous Vascular and Hemodialysis Access Studies

Billing and Coding, effective 2026-01-01 · Wisconsin Physicians Service Insurance Corporation (05101, 05102, 05201, 05202, 05301, 05302, 05401, 05402, 05901, 08101, 08102, 08201, 08202) · CMS record

597 covered ICD-10-CM codes in 3 groups; 5 procedure codes: 93970, 93971, 93985, 93986, 93990. Local policy: L35751 Non-Invasive Peripheral Venous Vascular and Hemodialysis Access Studies. Check a diagnosis for 93970.

First covered codes: D68.51 Activated protein C resistance; D68.52 Prothrombin gene mutation; D68.59 Other primary thrombophilia; D68.61 Antiphospholipid syndrome; D68.62 Lupus anticoagulant syndrome; D68.69 Other thrombophilia; …

A60315: Billing and Coding: Non-Invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities

Billing and Coding, effective 2026-06-08 · Novitas Solutions, Inc. (04111, 04112, 04211, 04212, 04311, 04312, 04411, 04412, 04911, 07101, 07102, 07201, 07202, 07301, 07302, 12101, 12102, 12201, 12202, 12301, 12302, 12401, 12402, 12501, 12502, 12901) · CMS record

413 covered ICD-10-CM codes; 4 procedure codes: 93925, 93926, 93930, 93931. Local policy: L35451 Peripheral Venous Ultrasound, L40276 Non-invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities. Check a diagnosis for 93925.

First covered codes: A48.0 Gas gangrene; E08.51 Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy without gangrene; E08.52 Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene; E08.59 Diabetes mellitus due to underlying condition with other circulatory complications; E09.51 Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy without gangrene; E09.52 Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene; …

A60318: Billing and Coding: Non-Invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities

Billing and Coding, effective 2026-06-08 · First Coast Service Options, Inc. (09101, 09102, 09201, 09202, 09302) · CMS record

413 covered ICD-10-CM codes; 4 procedure codes: 93925, 93926, 93930, 93931. Local policy: L33693 Peripheral Venous Ultrasound, L40289 Non-invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities. Check a diagnosis for 93925.

First covered codes: A48.0 Gas gangrene; E08.51 Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy without gangrene; E08.52 Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene; E08.59 Diabetes mellitus due to underlying condition with other circulatory complications; E09.51 Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy without gangrene; E09.52 Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene; …

How this NCD shows up on remittances

A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.

For teams evaluating QuickIntell software

Evaluate a coverage-review workflow around NCD 20.14

Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — NCD 20.14

What does NCD 20.14 cover?

Medicare coverage is extended to those procedures listed in Category I below when used for the accepted medical indications mentioned above. The procedures in Category II are still considered experimental and are not covered at this time. Denial of claims because a noncovered procedure was used or because there was no medical indication for plethysmographic evaluation of any type should be based on §1862(a)(1)… The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.

When did NCD 20.14 take effect?

The current version (1) is effective 11/15/1980. This is the only published version.

Does a Local Coverage Determination override NCD 20.14?

No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.